We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Chromogenex | LSE:CGX | London | Ordinary Share | GB00B0B7XX32 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.325 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
Hot Features
Premium
RNS Number : 2592U
Chromogenex PLC
13 May 2008
13 May 2008
Chromogenex plc
(the 'Company)
Canadian Health Approval
Further to the announcement made on the 14 April 2008, the Company is pleased to announce that it has now received the required medical
device licence from the Canadian Health Authority for an additional laser product, the Nlite-V Laser, allowing the Company to sell this
product in Canada.
Peter McGuinness, Executive Chairman, commented: "We are pleased to receive the anticipated outcome for another product by the Canadian
Health Authority. The Board had no doubt that this result would be reached due to the stringent testing of our products and now we have
approval for both the Chromolite-S and Nlite-V we look forward to the contribution that the sale of these products in Canada will add to our
revenues."
- ends -
Chromogenex PLC Tel: +44 20 8434 0540
Peter McGuinness, Chairman
HB Corporate
Luke Cairns Tel: +44 (0)20 7510 8600
Threadneedle Communications
Graham Herring/Alex White Tel: +44 (0)20 7936 9605
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCEAASAFEKPEAE
1 Year Chromogenex Chart |
1 Month Chromogenex Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
